AbMask™ & SynTac™ Platform

Conditional Activation or Co-stimulation T-Cell Engager

T-Cell Engager Technology Platform

PART 1

GenSci AbMask™ PRO-TCE Platform

Next-generation prodrug technology: Using structural biology as an engine to reshape the therapeutic window for tumor immunotherapy

PART 2

SynTac™ Co-stimulatory TCE Platform

Reconstructing Anti-tumor Immune Bridges to Empower Next-Generation Innovative Drug Development